Product Information
TYDEMY 3-0.03-0.451 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $2.9093 per EA under NDC 68180090473. Its NADAC has been published 124 times since Mar 10, 2021.
FDA first approved this application on Dec 12, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
TYDEMY 3-0.03-0.451 MG TABLET
Drospirenone, Ethinyl Estradiol and Levomefolate Calcium and Levomefolate CalciumManufacturer
Lupin Pharmaceuticals Inc.NDC
68180090473
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA205948FDA Approved
12/12/2017
TE Code
AB
On Market Since
11/20/2020
Price Statistics
The NADAC for TYDEMY 3-0.03-0.451 MG TABLET has been published 124 times since Mar 10, 2021, and over the history we have for it it has declined 36.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.9093 per EA |
|---|---|
| All-time high | $4.5983 (Sep 15, 2021) |
| All-time low | $2.9093 (Aug 19, 2026) |
| 52-week high | $3.2819 |
| 52-week low | $2.9093 |
| Median price | $3.2635 |
| Average price | $3.5391 |
| Largest weekly change | -22.1% (Apr 17, 2024) |
| Weeks tracked | 124 |
| Tracking since | Mar 10, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Drospirenone, Ethinyl Estradiol and Levomefolate Calcium and Levomefolate Calcium market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TYDEMY 3-0.03-0.451 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TYDEMY 3-0.03-0.451 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $2.9093 per EA (NDC 68180090473), effective Aug 19, 2026.
How has the price of TYDEMY 3-0.03-0.451 MG TABLET changed over time?
Over the history we have for it, the NADAC for TYDEMY 3-0.03-0.451 MG TABLET has declined 36.7%. It has been tracked across 124 weekly CMS publications since Mar 10, 2021.
What are the highest and lowest recorded NADAC prices for TYDEMY 3-0.03-0.451 MG TABLET?
Since Mar 10, 2021, the NADAC for TYDEMY 3-0.03-0.451 MG TABLET has ranged from a low of $2.9093 (Aug 19, 2026) to a high of $4.5983 (Sep 15, 2021), with a median of $3.2635 per EA.
Are there cheaper alternatives to TYDEMY 3-0.03-0.451 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of TYDEMY 3-0.03-0.451 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TYDEMY 3-0.03-0.451 MG TABLET?
TYDEMY 3-0.03-0.451 MG TABLET (NDC 68180090473) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.